Degradation mechanical performance testing quantifies how biodegradable medical implants—such as absorbable polymer devices, magnesium-alloy fixation systems, and bioresorbable scaffolds—retain their strength, stiffness, and structural integrity while degrading in simulated physiological environments. Guided by recognized standards including ASTM F1635, ISO 13781, ASTM F3260, and the ISO 10993 series, this testing is essential for design verification, absorption-profile substantiation, and regulatory submission. This article explains the sample types, testing items, methodologies, applications, and common questions associated with implant degradation mechanical performance evaluation.
Technical Overview
Biodegradable (bioresorbable) implants are engineered to provide temporary mechanical support during tissue healing and then to be absorbed gradually by the body, eliminating the need for revision surgery. Because the implant loses load-bearing capacity continuously as it degrades, designers and regulators must quantify exactly how fast mechanical properties decline and confirm that the device remains functional throughout the intended healing window. Degradation mechanical performance testing answers this question by exposing materials and finished devices to controlled in vitro degradation conditions that simulate the physiological environment, then measuring mechanical properties at predefined time points.
A comprehensive program combines mechanical characterization with physicochemical analysis—molecular weight, mass loss, water uptake, pH drift, crystallinity, and corrosion metrics—so that the loss of mechanical integrity can be correlated with the underlying degradation mechanism, whether hydrolytic chain scission in polymers or electrochemical corrosion in absorbable metals. Accredited third-party laboratories commonly conduct these studies under ISO/IEC 17025-aligned quality systems to support submissions to regulatory authorities worldwide.
- Polymer degradation standards: ASTM F1635 and ISO 13781 for hydrolytically degradable polymers and poly(L-lactide) resins
- Metallic degradation standards: ASTM F3260 for absorbable metallic materials and ASTM G31 for laboratory immersion corrosion testing
- Degradation product characterization: ISO 10993-13 (polymers), ISO 10993-14 (ceramics), and ISO 10993-15 (metals)
- Mechanical test methods: ISO 527 / ASTM D638 (tension), ISO 178 / ASTM D790 (flexure), ISO 604 / ASTM D695 (compression), ASTM E8/E8M (metallic tension), and ASTM E466 (fatigue)
Testing Samples
Absorbable Polymeric Resins and Fabricated Forms
Test coupons machined, injection-molded, or compression-molded from poly(L-lactide) (PLLA), poly(D,L-lactide) (PDLLA), polyglycolide (PGA), poly(lactide-co-glycolide) (PLGA), polycaprolactone (PCL), polydioxanone (PDO), and trimethylene carbonate copolymers. Standardized geometries include tensile dumbbells, flexural bars, and compression cylinders.
Absorbable Metallic Materials
Coupons and finished components made from high-purity magnesium, magnesium alloys such as Mg-Zn, Mg-Ca, WE43, and AZ31, zinc alloys such as Zn-Mg and Zn-Ag, and iron-based alloys. Metallic samples may also be tested in flow-loop configurations that reproduce the dynamic fluid conditions experienced by intravascular implants.
Bioabsorbable Ceramics and Composites
Beta-tricalcium phosphate, hydroxyapatite, biphasic calcium phosphates, bioactive glasses, and polymer-ceramic composites in the form of porous scaffolds, granules, blocks, and bone cements.
Finished Implant Devices
- Orthopedic and sports-medicine devices: interference screws, suture anchors, meniscal repair devices, plates, pins, and staples
- Cardiovascular devices: bioresorbable vascular scaffolds and stents
- General surgery and wound closure: absorbable sutures, meshes, films, and adhesion barriers
- Craniofacial and dental devices: resorbable membranes and fixation systems
Testing Items
The program tracks two parallel datasets: the mechanical property profile and the physicochemical degradation profile.
- Tensile strength, tensile modulus, and elongation at break as a function of degradation time
- Flexural strength and flexural modulus under three-point and four-point bending
- Compressive strength and compressive modulus
- Shear strength, torsional strength, and screw push-out or pull-out strength
- Bending strength of plate-screw constructs and cantilever bending of fixation pins
- Radial strength, crush resistance, and recoil for tubular scaffolds and stents
- Fatigue strength and cyclic durability after defined immersion periods
- Creep and stress-relaxation behavior under sustained physiological loading
- Molecular weight and molecular weight distribution by gel permeation chromatography, plus inherent viscosity
- Mass change, water absorption, and dimensional (swelling) change
- Medium pH monitoring, released ion quantification by ICP-MS or ICP-OES, and hydrogen evolution volume for metallic samples
- Thermal properties and crystallinity by DSC, phase analysis by XRD, and surface morphology by SEM
At each time point, the percentage retention of each mechanical property is calculated as the measured value divided by the time-zero value. This retention curve defines the mechanical integrity window of the implant and is compared against the clinically required healing period.
Testing Methods
In Vitro Degradation Conditioning
Samples are immersed in simulated body fluids—phosphate-buffered saline at pH 7.4, simulated body fluid prepared in accordance with ISO 23317, or Tris-HCl buffer—and incubated at 37 ± 1 °C to replicate core physiological temperature. The medium-to-specimen volume ratio is defined per ASTM F1635 or the study protocol so that accumulated degradation products do not suppress further degradation; media are refreshed on a documented schedule, and pH is recorded at each change. Aseptic handling, sterile filtration, or suitable preservatives prevent microbial degradation from contaminating the chemical degradation signal.
Time points are selected to bracket the intended functional period of the device—commonly 0, 1, 2, 3, 6, 9, and 12 months for polymers, with denser early sampling (hours to weeks) for fast-corroding magnesium and zinc devices. Testing continues until residual strength falls below a predefined threshold, frequently 30% retention, or until the claimed absorption milestone is reached.
Post-Degradation Mechanical Testing
At each time point, specimens are removed, gently blotted, and tested—typically in the wet state or after standardized conditioning—within a defined window to avoid drying artifacts. Tension is performed per ISO 527 or ASTM D638, flexure per ISO 178 or ASTM D790, and compression per ISO 604 or ASTM D695; metallic specimens follow ASTM E8/E8M. Fatigue after immersion may follow ASTM E466, while vascular scaffold durability is evaluated consistent with ASTM F2477. A minimum of five replicates per time point per test is customary, with results reported as mean ± standard deviation and statistically compared against time-zero controls.
Accelerated Degradation
Screening studies frequently employ elevated temperatures, increased ionic strength, or alkaline pH to accelerate hydrolysis or corrosion, with kinetics interpreted through Arrhenius-type models. Accelerated data are valuable for ranking candidate materials and formulations but do not replace real-time studies when substantiating the labeled degradation profile for regulatory submissions.
Corrosion Evaluation for Absorbable Metals
Metallic samples are evaluated using ASTM G31 immersion principles and ASTM F3260 guidance: mass-loss corrosion rate converted to millimeters per year, hydrogen gas evolution volume, pH drift, released ion quantification, and corroded-surface characterization. Dynamic immersion at physiological flow rates is recommended for intravascular devices, and electrochemical methods such as open-circuit potential monitoring, potentiodynamic polarization, and electrochemical impedance spectroscopy complement the immersion data.
Data Analysis and Reporting
The final deliverable presents mechanical property retention curves, half-strength time estimates, correlation of mechanical decline with molecular weight or mass loss, and photographic and SEM documentation of specimen condition at each interval. Conclusions state the demonstrated mechanical integrity window and its alignment with the intended clinical healing period.
Applications
- Regulatory submissions demonstrating that bioresorbable devices maintain mechanical function for the claimed period before safely losing integrity
- Research and development screening of polymers, alloys, coatings, and surface treatments for degradation-tunable performance
- Design verification of orthopedic fixation devices where strength retention must match bone-healing timelines
- Cardiovascular scaffold development combining radial strength retention with durability and absorption profiling
- Equivalence studies following manufacturing, sterilization (gamma, electron beam, ethylene oxide), or packaging changes
- Shelf-life support linking storage aging with subsequent in-use degradation behavior
- Academic research and patent substantiation for novel biodegradable biomaterials
FAQ
Q: Why is degradation mechanical performance testing required for biodegradable implants?
A: Because these devices must carry load during healing and then disappear, regulators require objective evidence of how strength declines over time. The retention curves demonstrate that the implant remains mechanically functional long enough to support tissue repair and does not fail prematurely.
Q: Which standards govern the testing?
A: ASTM F1635 and ISO 13781 cover in vitro degradation of absorbable polymers, ASTM F3260 addresses absorbable metallic materials, ASTM G31 governs immersion corrosion of metals, and ISO 10993-13, ISO 10993-14, and ISO 10993-15 address degradation product characterization. Mechanical methods draw on ISO 527, ISO 178, ISO 604, ASTM D638, ASTM D790, ASTM D695, ASTM E8/E8M, and ASTM E466.
Q: What medium and temperature are used?
A: Phosphate-buffered saline, simulated body fluid per ISO 23317, or Tris-HCl buffer at pH 7.4 ± 0.2, held at 37 ± 1 °C, with defined medium-to-sample ratios and scheduled refreshment to keep degradation conditions representative.
Q: How long does a study take?
A: Real-time programs for polymers commonly run 6 to 24 months depending on the claimed absorption period; magnesium and zinc devices may complete their mechanical profile within weeks to a few months. Accelerated protocols can shorten screening to a few weeks.
Q: How many specimens are needed?
A: Typically at least five replicate specimens per time point per mechanical test, plus parallel specimens dedicated to mass, molecular weight, pH, ion release, and morphology measurements, with spare specimens reserved for valid retests.
Q: Do absorbable metals require different handling than polymers?
A: Yes. Metallic testing adds corrosion-rate measurement, hydrogen evolution collection, ion-release analysis, and often dynamic flow exposure, since corrosion behavior is highly sensitive to fluid flow and dissolved oxygen.
Q: Can the results support submissions to multiple regulatory authorities?
A: Yes. Studies performed by accredited third-party laboratories under ISO/IEC 17025-aligned quality systems and designed against the standards above are widely accepted in support of premarket submissions across major jurisdictions.